VSee Health Inc. Faces Potential Nasdaq Delisting Due to Regulatory Non-Compliance and Equity Deficit

Reuters
09/06
<a href="https://laohu8.com/S/VSEE">VSee Health</a> Inc. Faces Potential Nasdaq Delisting Due to Regulatory Non-Compliance and Equity Deficit

VSee Health Inc. is facing potential delisting from the Nasdaq Stock Market due to multiple compliance issues. The company received notifications from Nasdaq regarding its failure to timely file its financial reports for the fiscal year ended December 31, 2024, and the first two quarters of 2025. Additionally, VSee Health Inc. is not in compliance with Nasdaq's equity requirements, as its stockholders' equity has fallen below the $2,500,000 minimum threshold. A hearing with the Nasdaq Hearings Panel is scheduled for September 9, 2025, where the company plans to address these deficiencies. If trading is suspended, VSee Health Inc. expects its stock and public warrants to trade on the OTC Markets system under their current symbols.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-25-001135), on September 05, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10